Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).
Jakob J MalinChristoph D SpinnerUwe JanssensTobias WelteSteffen Weber-CarstensGereon SchältePetra GastmeierFlorian LangerMartin WeplerMichael WesthoffMichael PfeiferKlaus F RabeFlorian HoffmannBernd W BöttigerJulia Weinmann-MenkeAlexander KerstenPeter BerlitMarcin KrawczykWiebke NehlsFalk FichtnerSven LaudiMiriam Songa StegemannNicole SkoetzMonika NothackerGernot MarxChristian KaragiannidisStefan KlugePublished in: Infection (2021)
For COVID-19 drug therapy, there are several options that are sufficiently supported by evidence. The living guidance will be updated as new evidence emerges.